These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 21355078)

  • 1. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma.
    Frigola X; Inman BA; Lohse CM; Krco CJ; Cheville JC; Thompson RH; Leibovich B; Blute ML; Dong H; Kwon ED
    Clin Cancer Res; 2011 Apr; 17(7):1915-23. PubMed ID: 21355078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble B7-H1: differences in production between dendritic cells and T cells.
    Frigola X; Inman BA; Krco CJ; Liu X; Harrington SM; Bulur PA; Dietz AB; Dong H; Kwon ED
    Immunol Lett; 2012 Feb; 142(1-2):78-82. PubMed ID: 22138406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
    Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
    Thompson RH; Kuntz SM; Leibovich BC; Dong H; Lohse CM; Webster WS; Sengupta S; Frank I; Parker AS; Zincke H; Blute ML; Sebo TJ; Cheville JC; Kwon ED
    Cancer Res; 2006 Apr; 66(7):3381-5. PubMed ID: 16585157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.
    Zhang G; Hou J; Shi J; Yu G; Lu B; Zhang X
    Immunology; 2008 Apr; 123(4):538-46. PubMed ID: 18194267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
    Thompson RH; Dong H; Kwon ED
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.
    Quandt D; Jasinski-Bergner S; Müller U; Schulze B; Seliger B
    J Transl Med; 2014 May; 12():151. PubMed ID: 24885059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
    Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of B7-H1 overexpression in kidney cancer.
    Thompson RH; Kwon ED
    Clin Genitourin Cancer; 2006 Dec; 5(3):206-11. PubMed ID: 17239274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.
    Crispen PL; Sheinin Y; Roth TJ; Lohse CM; Kuntz SM; Frigola X; Thompson RH; Boorjian SA; Dong H; Leibovich BC; Blute ML; Kwon ED
    Clin Cancer Res; 2008 Aug; 14(16):5150-7. PubMed ID: 18694993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine.
    Webster WS; Thompson RH; Harris KJ; Frigola X; Kuntz S; Inman BA; Dong H
    J Immunol; 2007 Sep; 179(5):2860-9. PubMed ID: 17709500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Krejci KG; Lobo JR; Sengupta S; Chen L; Zincke H; Blute ML; Strome SE; Leibovich BC; Kwon ED
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17174-9. PubMed ID: 15569934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.
    Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
    Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma.
    Chen W; Liu P; Wang Y; Nie W; Li Z; Xu W; Li F; Zhou Z; Zhao M; Liu H
    PLoS One; 2013; 8(10):e76965. PubMed ID: 24194851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.
    Boorjian SA; Sheinin Y; Crispen PL; Farmer SA; Lohse CM; Kuntz SM; Leibovich BC; Kwon ED; Frank I
    Clin Cancer Res; 2008 Aug; 14(15):4800-8. PubMed ID: 18676751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma.
    Tatsumi T; Herrem CJ; Olson WC; Finke JH; Bukowski RM; Kinch MS; Ranieri E; Storkus WJ
    Cancer Res; 2003 Aug; 63(15):4481-9. PubMed ID: 12907621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus.
    Xiao JP; Wang XR; Zhang S; Wang J; Zhang C; Wang DG
    Iran J Immunol; 2019 Mar; 16(1):43-52. PubMed ID: 30864554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
    Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features.
    Hong B; Cai L; Wang J; Liu S; Zhou J; Ma K; Zhang J; Zhou B; Peng X; Zhang N; Gong K
    Clin Genitourin Cancer; 2019 Apr; 17(2):97-104.e1. PubMed ID: 30522901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.
    Routh JC; Ashley RA; Sebo TJ; Lohse CM; Husmann DA; Kramer SA; Kwon ED
    J Urol; 2008 May; 179(5):1954-9; discussion 1959-60. PubMed ID: 18355839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.